NF2 and ovarian carcinoma: Deletion and loss-of-function mutations of NF2 are associated with development and/or invasiveness of several cancers such as schwannomas, meningiomas, ependymomas, mesothelioma, endometrial cancer, ovarian cancer, glioblastoma, and breast cancer [57,58].